Related Experiment Video

Updated: May 27, 2026

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals
07:39

A Murine Pancreatic Islet Cell-based Screening for Diabetogenic Environmental Chemicals

Published on: June 25, 2018

Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine

Meritxell Rovira1, Wei Huang, Shamila Yusuff

  • 1Department of Surgery, and McKusick-Nathans Institute for Genetic Medicine, The Johns Hopkins University, Baltimore, MD 21205, USA.

Proceedings of the National Academy of Sciences of the United States of America
|November 16, 2011
PubMed

Insights

Researchers screened drugs to find compounds that promote insulin-producing beta-cell differentiation in zebrafish. Six compounds were identified, revealing new pathways for beta-cell development and potential type 1 diabetes therapies.

Area of Science:

  • Endocrinology
  • Developmental Biology
  • Pharmacology

Background:

  • Pancreatic beta-cells produce insulin, vital for glucose regulation.
  • Autoimmune destruction of beta-cells leads to type 1 diabetes.
  • Identifying compounds to regenerate beta-cells is crucial for diabetes treatment.

Purpose of the Study:

  • To screen for chemical compounds that induce in vivo differentiation of insulin-producing beta-cells.
  • To identify novel pathways regulating beta-cell development.

Main Methods:

  • Chemical screen using transgenic zebrafish model for beta-cell differentiation.
  • Utilized a multiwell plate for easy visualization of larval fish.
  • Screened a library of clinical drugs.

Main Results:

  • Identified six compounds that induce precocious differentiation of secondary islets in larval zebrafish.
  • Three compounds were known drugs with established mechanisms.
  • Characterized two novel pathways: GTP production down-regulation and retinoic acid biosynthesis.

Conclusions:

  • The study identified compounds and pathways that promote beta-cell differentiation in vivo.
  • Findings provide a foundation for developing new therapeutic strategies for type 1 diabetes.
  • Zebrafish serve as a valuable model for studying beta-cell development and drug discovery.

More Related Videos

Single-cell Transcriptomic Analyses of Mouse Pancreatic Endocrine Cells10:05

Single-cell Transcriptomic Analyses of Mouse Pancreatic Endocrine Cells

Published on: September 30, 2018

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro09:33

Generation of Scaffold-free, Three-dimensional Insulin Expressing Pancreatoids from Mouse Pancreatic Progenitors In Vitro

Published on: June 2, 2018

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...